Explore the details of the Novo Nordisk Inc. V. Mylan Pharmaceuticals Inc. case under case number 1:24-cv-01013 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-01013
Filing Date
Sep 5, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Novo Nordisk A/S -
Mylan Pharmaceuticals Inc. -

Patents Involved in the Case

There is a single patent involved in this case.

Application NumberPatent Number
-US12029779B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Sep 6, 2024Remark: MDL Panel has been notified. (mws)PACER Document
Sep 11, 2024WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Mylan Pharmaceuticals Inc. waiver sent on 9/10/2024, answer due 11/12/2024. (Murray, Travis) (Entered: 09/11/2024)PACER Document
Sep 11, 2024STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 09/11/2024)PACER Document
Nov 6, 2024NOTICE OF SERVICE of (1) Defendants Initial Invalidity Contentions Regarding U.S. Patent No. 12,029,779 and (2) Defendants Initial Non-Infringement Contentions Regarding U.S. Patent No. 12,029,779 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 11/06/2024)PACER Document
Nov 12, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 11/12/2024)PACER Document
Nov 12, 2024ANSWER to 1 Complaint, COUNTERCLAIM against All Plaintiffs by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 11/12/2024)PACER Document
Nov 22, 2024[SEALED] Letter to The Honorable Colm F. Connolly from Travis J. Murray regarding proposed schedules - re (12 in 1:24-cv-01013-CFC, 227 in 1:23-cv-00101-CFC) Joint MOTION and [Proposed] Order to Consolidate Case No. 24-1013-CFC into Lead Case No. 23-101-CFC . (Attachments: # 1 Exhibit A)(Murray, Travis) (Entered: 11/22/2024)PACER Document
Nov 22, 2024Joint MOTION and [Proposed] Order to Consolidate Case No. 24-1013-CFC into Lead Case No. 23-101-CFC - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis) (Entered: 11/22/2024)PACER Document
Nov 26, 2024REDACTED VERSION of (228 in 1:23-cv-00101-CFC, 13 in 1:24-cv-01013-CFC) Letter, by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Ex. A)(Murray, Travis) (Entered: 11/26/2024)PACER Document
Dec 3, 2024ANSWER to 10 Answer to Complaint, Counterclaim by Novo Nordisk Inc., Novo Nordisk A/S.(Murray, Travis) (Entered: 12/03/2024)PACER Document
Dec 6, 2024ORDER granting (227 in 23-101, 12 in 24-1013) Joint MOTION and [Proposed] Order to Consolidate Case No. 24-1013-CFC into Lead Case No. 23-101-CFC. These actions are consolidated for all purposes, and all papers shall be filed in C.A. No. 23-101-CFC. The Protective Order (C.A. No. 23-101-CFC, D.I. 40) and ESI Order (C.A. No. 23-101-CFC, D.I. 43) shall govern. The Scheduling Order shall be modified by the Proposed Consolidated Case Schedule and shall govern. Signed by Judge Colm F. Connolly on 12/6/2024. Associated Cases: 1:23-cv-00101-CFC, 1:24-cv-01013-CFC (mws) Modified on 12/6/2024 (mws). (Entered: 12/06/2024)PACER Document
Nov 26, 2024REDACTED VERSION of (228 in 1:23-cv-00101-CFC, 13 in 1:24-cv-01013-CFC) Letter, by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Ex. A)(Murray, Travis) (Entered: 11/26/2024)Attachment
Sep 11, 2024Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:24-cv-01013-CFC, 1:24-cv-01014-CFC (rjb)PACER Document
Dec 3, 2024ORAL ORDER Setting Hearings: re (228 in 1:23-cv-00101-CFC, 13 in 1:24-cv-01013-CFC) Letter, (A Scheduling Teleconference is set for 12/6/2024 at 09:00 AM Telephonically before Judge Colm F. Connolly). Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 12/3/2024. Associated Cases: 1:23-cv-00101-CFC, 1:24-cv-01013-CFC(mws)PACER Document
Dec 6, 2024Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 12/6/2024. (Court Reporter Bonnie Archer.) Associated Cases: 1:23-cv-00101-CFC, 1:24-cv-01013-CFC(mws)PACER Document
Dec 6, 2024Case associated with lead case: Create association to 1:23-cv-00101-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 23-101-CFC ONLY. (mws)PACER Document